ALC

Alcon AG
NYSEHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES

Key Statistics

Market Cap
$35.04B
P/E Ratio
56.63
EPS
$1.28
Beta
0.69
52W High
$87.22
52W Low
$61.84
50-Day MA
$68.48
200-Day MA
$74.67
Dividend Yield
0.48%
Profit Margin
5.92%
Forward P/E
21.46
PEG Ratio
1.53

About Alcon AG

Alcon, Inc., an eye care company, researches, develops, manufactures, distributes and sells eye care products for eye care professionals and their patients around the world. The company is headquartered in Geneva, Switzerland.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$10.86B
Gross Profit (TTM)$6.21B
EBITDA$2.40B
Operating Margin14.60%
Return on Equity2.94%
Return on Assets2.80%
Revenue/Share (TTM)$22.21
Book Value$44.67
Price-to-Book1.66
Price-to-Sales (TTM)3.23
EV/Revenue3.671
EV/EBITDA14.61
Quarterly Earnings Growth (YoY)-44.60%
Quarterly Revenue Growth (YoY)8.70%
Shares Outstanding$483.40M
Float$481.83M
% Insiders0.20%
% Institutions66.02%

Historical Volatility

HV 10-Day
32.19%
HV 20-Day
29.78%
HV 30-Day
29.68%
HV 60-Day
28.05%
HV Rank
73.0%

Volatility is currently expanding

Analyst Ratings

Consensus ($85.24 target)
5
Strong Buy
17
Buy
3
Hold
1
Strong Sell

Latest News

Alcon: A Strong Company Trading Close To Its Intrinsic Value, Buy

Alcon reported strong core operating profit (barring a one-time non-cash $402 million charge) during the quarter, up 17%. The company raised its full-year 2026 profit forecast for the second consecutive quarter. My DCF valuation states the stock is undervalued by 5.52%. I rate ALC a buy.

Seeking Alpha8/17/2026Positive

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ALC and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 8/18/2026